The role of therapeutic inertia and the use of fixed-dose combination therapy in the management of hypertension.
Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
Jan
J
Basile
Henry R
HR
Black
John M
JM
Flack
Joseph L
JL
Izzo
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D006040:Goals; D006801:Humans; D006973:Hypertension / Q000178:diet therapy / Q000188:drug therapy*
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents